Eighty-kilodalton N-terminal moiety of Bordetella pertussis filamentous hemagglutinin: Adherence, immunogenicity, and protective role

Infection and Immunity

Volumn 70, Issue 8, 2002, Pages 4142-4147

  Alonso, Sylvie ^a   Reveneau, Nathalie ^a   Pethe, Kévin ^a   Locht, Camille ^a  

^a INSTITUT DE BIOLOGIE DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; FILAMENTOUS HEMAGGLUTININ 44; HEMAGGLUTININ; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ADHERENCE; BORDETELLA PERTUSSIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOGENICITY; IMMUNOMODULATION; MOUSE; NONHUMAN; PERTUSSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PURIFICATION; RESPIRATORY TRACT INFECTION;

ADHESINS, BACTERIAL; AMINO ACID MOTIFS; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL ADHESION; BORDETELLA PERTUSSIS; CELL LINE; DISEASE MODELS, ANIMAL; HEMAGGLUTININS; HUMANS; IMMUNIZATION, PASSIVE; LUNG; MICE; MICE, INBRED BALB C; MOLECULAR WEIGHT; VIRULENCE FACTORS, BORDETELLA; WHOOPING COUGH;

EID: 0036078538     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.8.4142-4147.2002     Document Type: Article

References (42)

1. Role of ADP-ribosyltransferase activity of pertussis toxin in toxin-adhesin redundancy with filamentous hemagglutinin during Bordetella pertussis infection
2. Roles of the disulfide bond and the carboxyterminal region of the S1 subunit in the assembly and biosynthesis of pertussis toxin
3. Role of adhesins and toxins in invasion of human tracheal epithelial cells by Bordetella pertussis
4. Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles
5. Mice are protected against Bordetella pertussis infection by intra-nasal immunization with filamentous haemagglutinin
6. Historical review of pertussis and the classical vaccine
7. Comparison of 13 acellular pertussis vaccines: Adverse reactions
8. Animal models of pneumocystosis
9. Cloning, partial sequence, expression, and antigenic analysis of the filamentous hemagglutinin gene of Bordetella pertussis
10. Comparison of 13 acellular pertussis vaccines: Overview and serologic response
11. Reflections on the efficacy of pertussis vaccines
12. Adenylate cyclase toxin is critical for colonization and pertussis toxin is critical for lethal infection by Bordetella pertussis in infant mice
13. Sulfated glycoconjugate receptors for the Bordetella pertussis adhesin filamentous hemagglutinin (FHA) and mapping of the heparin-binding domain on FHA
14. Virulence factors determine attachment and ingestion of nonopsonized Bordetella pertussis by human monocytes
15. Report of adverse reactions associated with new DTP vaccine available in Japan
16. Two-partner secretion in gram-negative bacteria: A thrifty, specific pathway for large virulence proteins
17. Characterization of murine lung inflammation after infection with parental Bordetella pertussis and mutants deficient in adhesins or toxins
18. Both adenylate cyclase and hemolytic activities are required by Bordetella pertussis to initiate infection
19. Bordetella pertussis filamentous hemagglutinin: Evaluation as a protective antigen and colonization factor in a mouse respiratory infection model
20. Immunodominant domains present on the Bordetella pertussis vaccine component filamentous hemagglutinin
21. The filamentous haemagglutinin, a multifaceted adhesin produced by virulent Bordetella spp
22. Common accessory genes for the Bordetella pertussis filamentous haemagglutinin and fimbriae share sequence similarities with the papC and papD gene families
23. Identification and purification of transferrin- and lactoferrin-binding proteins of Bordetella pertussis and Bordetella bronchiseptica
24. Interaction of the Bordetella pertussis filamentous haemagglutinin with heparin
25. Heparin-inhibitable lectin activity of the filamentous hemagglutinin adhesin of Bordetella pertussis
26. Mouse-protecting and histaminesensitizing activities of pertussigen and fimbrial hemagglutinin from Bordetella pertussis
27. Protective activities of the filamentous hemagglutinin and the lymphocytosis-promoting factor of Bordetella pertussis in mice
28. Identification of immunodominant epitopes in the filamentous haemagglutinin of Bordetella pertussis
29. The acellular pertussis vaccine trials: An interpretation
30. Symptoms after primary immunization with DTP and DT vaccine
31. Identification of a carbohydrate recognition domain in filamentous hemagglutinin from Bordetella pertussis
32. Versatile suicide vectors which allow direct selection for gene replacement in gram-negative bacteria
33. 2 CD11b/CD18) binds filamentous hemagglutinin of, Bordetella pertussis
34. Distinct roles of the N-terminal and C-terminal precursor domains in the biogenesis of the Bordetella pertussis filamentous hemagglutinin
35. Adjuvanticity and protective immunity elicited by Bordetella pertussis antigens encapsulated in poly(DL-lactide-co-glycolide) microspheres
36. Mucosal immunization with filamentous hemagglutinin protects against Bordetella pertussis respiratory infection
37. Construction and characterization of new cloning vehicles. IV. Deletion derivatives of pBR322 and pBR325
38. Use of conditionally counterselectable suicide vectors for allelic exchange
39. Secondary analysis of the efficacy of two acellular vaccines evaluated in a Swedish phase III trial
40. Role of Bordetella pertussis virulence factors in adherence to epithelial cell lines derived from the human respiratory tract
41. Pertussis toxin and extracytoplasmic adenylate cyclase as virulence factors of Bordetella pertussis
42. Antigenic analysis of Bordetella pertussis filamentous hemagglutinin with phage display libraries and rabbit anti-filamentous hemagglutinin polyclonal antibodies